Eprex (recombinant human erythropoietin alfa) and pure red cell aplasia--recommendations for administration to patients with CRF.
D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects*; D006287:Health Planning Guidelines; D006801:Humans; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000453:epidemiology; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000453:epidemiology
D011994:Recombinant Proteins; D004921:Erythropoietin